Abstract
The antiepileptic activity of the imidazole derivative denzimol has been evaluated in 10 patients with poorly controlled partial epilepsy by adding on the drug to the current therapy, in an open preliminary trial. A sustained drop in seizure frequency greater than 50% occurred in 5 patients. Although denzimol increased blood concentrations of carbamazepine, correlation analysis indicated that the improvement was more likely due to intrinsic properties of denzimol. No severe side effects were reported, although several patients experienced nausea and vomiting, which caused 2 patients to drop out.
Sommario
L'attività antiepilettica del denzimol, derivato imidazolico, è stata preliminarmente valutata in un gruppo di 10 pazienti affetti da epilessia parziale scarsamente controllata dalle terapie convenzionali, secondo un disegno sperimentale aperto, “add-on”. In 5 pazienti vi è stata una riduzione della frequenza delle crisi superiore al 50% rispetto al valore pre-trattamento. Sebbene il denzimol tenda ad aumentare i tassi plasmatici della carbamazepina, l'analisi della correlazione ha dimostrato che il miglioramento è in larga misura dovuto a proprietà intrinseche del denzimol. Non sono stati evidenziati effetti collaterali di particolare rilevanza, anche se numerosi pazienti hanno presentato nausea e vomito, che in due casi hanno determinato la sospensione del farmaco.
Similar content being viewed by others
References
Abbiati G.A., Bertin D., Ibba M., Graziani G., Testa R.:Relationship between plasma and brain concentrations of denzimol and its anticonvulsant and neurotoxic effects in the rat. Arch. Int. Pharmacodyn. Ther. 280: 117–128, 1986.
Graziani G., Barbadoro E., Testa R.:Denzimol: a new anticonvulsant drug. III. Toxicological evaluation. Arzneim. Forsch. 33: 1168–1173, 1983.
Graziani G., Tirone F., Barbadoro E., Testa R.:Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile. Arzneim. Forsch. 33: 1155–1160, 1983.
Ibba M., Mennini T., Testa R.:Enhancement of diazepam activities induced by denzimol in mice. Pharmacol. Res. Comm., 17: 95–103, 1985.
Ibba M., Vanasia A., Testa R.:Differential antagonism of denzimol to various components of metrazol-induced seizures in rats and mice. Pharmacol. Res. Comm. 17: 1169–1180, 1985.
Nardi D., Tajana A., Leonardi A., Pennini R., Portioli F., Magistretti M.J., Subissi A.:Synthesis and anticonvulsant activity of N-(Benzoylalkyl) imidazoles and N-(-Phenyl-hydroxyalkyl) imidazoles. J. Med. Chem. 24: 727–731, 1981.
Patsalos P.N., Shorvon S.D., Elyas A.A., Smith G.:The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin. J. Neurol. Neurosurg. Psychiat. 48:374–377, 1985.
Smirne S., Crippa D., Bertin D., Franceschi M., Perego L., Tajana A., Bareggi S.,Pharmacological, pharmacokinetic and clinical study of Denzimol, a new anticonvulsant drug. Abstracts of the 15th Epilepsy International Symposium, Washington, Sept. 26–30, 1983, p. 363.
Smirne S., Franceschi M., Bareggi S., Perego L. Cattoni M., Cornelli U., Ferini-Strambi L.:Denzimol, a new anticonvulsant drug, in the treatment of partial epilepsy. Abstracts of the 16th Epilepsy International Congress, Hamburg, Sept. 6–9, 1985.
Veronese M., Barzaghi D., Bertoncini A., Zadro M.:Mutagenicity studies on denzimol, a new anticonvulsant drug. Arzneim. Forsch. 35: 793–796, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benassi, E., Cocito, L., Maffini, M. et al. Preliminary note on the effect of denzimol in partial epilepsy. Ital J Neuro Sci 9, 331–335 (1988). https://doi.org/10.1007/BF02333995
Issue Date:
DOI: https://doi.org/10.1007/BF02333995